T1	Participants 147 191	cytological screening for endometrial cancer
T2	Participants 443 489	315 women (premenopause 251, postmenopause 64)
T3	Participants 0 25	Endometrial cytodiagnosis
T4	Participants 1073 1105	screening for endometrial cancer
